Oulu, Finland, August 24, 2022 – Bittium will participate in the European Society of Cardiology (ESC) Congress held in Barcelona on 26-29 August 2022. The ESC Congress focuses on the research and treatment of cardiovascular diseases, and this year marks 70 years since the first ESC Congress.
Bittium’s team of Medical Technologies experts will showcase our latest solutions for cardiac monitoring that enable long-term ECG measurements and recordings, early detection of cardiac arrhythmias, and cardiac event monitoring. The new Bittium Faros™ 180L ECG measuring device, which was released in the spring, will be on display at the event. The Bittium Faros™ 180L measures at least 14 consecutive days on a single battery charge streamlining prolonged ECG monitoring, for example, in stroke patients and improving diagnostic yield of Holter monitoring and patient compliance. Bittium´s solutions enable the earlier discharge of patients and the ability to detect and react to arrhythmias faster.
All Bittium’s medical products can be integrated with the cloud-based back-end systems enabling seamless workflow and analysis of data regardless of location. These innovations not only equip clinicians with smarter diagnostics tools but also offer healthcare providers more efficient, time- and resource-saving solutions that are well suited for remote, preventative, and home-based care. The importance of remote care and remote monitoring has increased during the Covid-19 pandemic due to insufficient medical resources and cost pressures. Bittium’s remote monitoring and remote diagnostics solutions can provide solutions for these challenges and allow access to treatment for more patients.
The Medical Technologies team is located at stand I630 exhibiting the following products and solutions:
To register for the event, please visit https://www.escardio.org/Congresses-&-Events/ESC-Congress
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507
In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, and sports medicine. In addition, Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, and customized solutions based on its product platforms and R&D services. Net sales in 2021 were EUR 86.9 million and operating profit was EUR 3.2 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com